← SynDRA
FASIGLIFAM
SynDRA canonical compound SYN0027797 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | FFAR1 |
|---|
| Mechanism of action | Insulin secretagogue |
|---|
All known targets
Mechanisms of action (all sources)
- Insulin secretagogue
- FFAR1 POSITIVE ALLOSTERIC MODULATOR
- Free fatty acid receptor 1 positive allosteric modulator
- FFAR1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCC2
- SLCO1B1
- SLC10A1
- PPARA
- MPG
- MUTYH
- NEIL1
- NEIL2
- NTHL1
- OGG1
- PPARD
- HDAC6
- PPARG
- S1PR1
- SLCO1B3
- SMUG1
- TDG
- MBD4
- GPR35
- ADGRF1
- GPR119
- ADRA2A
- ADRB2
- AGTR1
- APLNR
- C5AR1
- CX3CR1
- CYP1A2
- CYP2C9
- CYP2D6
- CYP3A4
- FFAR2
- FFAR3
- FFAR4
- FPR2
- GLP1R
- UNG
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP2C9
- CP3A7
- GNA15
- NTM1A
- NTMT1
Cross-references
Synonyms
- FASIGLIFAM HYDRATE
- FASIGLIFAM HEMIHYDRATE
- TAK-875 ANHYDROUS
- AK875
- CPD 9A
- TAK-875
- TAK875
- Fasiglifam hemihydrate
- UNII-8LDT91CH8A
- 8LDT91CH8A
- TAK-875 Hemihydrate
- Fasiglifam hydrate (JAN)
- DTXSID80160191
- MolPort-035-395-707
- EX-A2165
- s2637
- AKOS025404925
- 3-Benzofuranacetic acid, 6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)(1,1'-biphenyl)-3-yl)methoxy)-2,3-dihydro-, hydrate (2:1), (3S)-
- (3S)-6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy) biphenyl-3-yl)methoxy)-2,3-dihydro-l-benzofuran-3-yl)acetic acid hydrate
- SC-95595
- BC600332
- (3S)-6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)
- TAK 875
- UNII-GLP1W4JXAH
- GLP1W4JXAH
- (S)-2-(6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid
- CHEMBL1829174
- [(3s)-6-({2',6'-Dimethyl-4'-[3-(Methylsulfonyl)propoxy]biphenyl-3-Yl}methoxy)-2,3-Dihydro-1-Benzofuran-3-Yl]acetic Acid
- 3-Benzofuranacetic acid, 6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-, (3S)-
- J-501277
- Tak-875 anhydrous
- fasiglifamum
- RefChem:921483
- DTXCID301509991
- TAK-875(Fasiglifam)
- MFCD18251445
- C29H32O7S
- Fasiglifam [INN]
- Fasiglifam [USAN:INN]
Look up FASIGLIFAM in the interactive SynDRA portal →